Ads
related to: sanofi- Type 1 Diabetes FAQs
Get Answers to Your FAQs About
T1D and Screening Early for T1D
- What You Need to Know
Learn the Risk Factors of T1D.
Take the Type 1 Risk Quiz
- T1D Risk Factors
Take the Type 1 Risk Quiz to
Understand Your Risk Factor for T1D
- Take the 1 Pledge
Take the Pledge to Screen
for Type 1 Diabetes. Learn More.
- Screen Early for T1D
Learn the Importance of
Screening Early
- Know Your Options
Screen Early for Type 1 Diabetes &
Start Planning for the Future.
- Type 1 Diabetes FAQs
Search results
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
Fortune via AOL· 8 hours agoGood morning from Geneva. If generative AI is going to be more than hype and hallucinations, the...
Feds plan for smoother access to RSV infant shot
Politico· 2 hours agoThe government has repeatedly met with vaccine makers AstraZeneca and Sanofi in recent months to ensure there is enough supply early in the season after unanticipated demand ...
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe US Food and Drug Administration (FDA) has accepted for priority review Sanofi's supplemental...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 2 days agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate
Zacks via Yahoo Finance· 5 hours agoJ&J (JNJ) is set to acquire Yellow Jersey Therapeutics, which holds NM26 rights, from Numab's...
Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data
Zacks via Yahoo Finance· 1 hour agoData from a late-stage study shows that treatment with Insmed's (INSM) brensocatib reduced episodes...
France against Servier selling generics unit Biogaran, PM says
Reuters via AOL· 5 hours agoPARIS (Reuters) -The French government has told drugmaker Servier it is against any sale of its...
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena via Yahoo Finance· 6 days agoSanofi has announced positive outcomes from a Phase II clinical trial of rilzabrutinib, an oral...
PNC Financial Services Group Inc. Sells 93,285 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 4 days agoPNC Financial Services Group Inc. lowered its position in Sanofi (NASDAQ:SNY – Free Report) by 48.1% during the fourth quarter, Holdings Channel reports. The institutional ...
Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
The Yuma Sun· 5 days agoInhibrx, Inc. (Nasdaq: INBX) ("Inhibrx," or the "Company") announced that, at a special meeting (the "Special Meeting"), the Company's stockholders approved the sale to Sanofi
Ads
related to: sanofi